Craig Morgan

Articles

The Emergence of the Few: M&A in the CRO Industry

October 30, 2017

As the size, complexity, duration, cost, and globalization of clinical trials has grown, pharmaceutical and biotech companies have moved to outsource clinical activities to CROs to achieve a wide range of objectives.